Level 42 AI

04/17/2024

Exciting times showcasing our solutions for rapid screening of disease and injury at the DTRA CBOA 2024 at Camp Lejeune during this week.
Overheard some of the warfighters talking: "I would use the imPulse Una, it is really Army proof"
https://www.youtube.com/watch?v=LEERg8xLw44

DTRA kicks off the CBDP’s annual Chem Bio Operation Analysis or CBOA, a week-long field experiment that allows Joint Force members to test on-the-horizon tec...

08/31/2023

Level 42 AI is proud to announce we were selected from thousands of companies as a Quarterfinalist for The Digital Health Hub Foundation Digital Health Awards (tag) 2023 in the Best in Class - Longevity category! The Digital Health Awards honor outstanding health technologies and innovations dramatically transforming healthcare.
https://www.linkedin.com/company/digitalhealthhubfoundation/?viewAsMember=true

08/29/2023

https://www.einpresswire.com/article/652467205/level-42-ai-announces-development-partnership-with-parts-express

Vibroacoustic sensors and devices to hear the ‘unheard’ and feel the ‘unfelt’ without contact for early disease/failure detection using program synthesis and AI

08/11/2023

Startup life is hard at times, so awards like this one certainly makes you feel more energized!

The human body resembles a musical orchestra. The real-time “noise” generated by the human body is an underexplored data source for biomarker discovery.

02/22/2023

We are very proud and excited to be among this group of highly innovative companies!

NEW: 12 have been selected for the Spring 2023 cohort of FAST California! After receiving a record number of applicants, this is our LARGEST cohort to date!
🚀BCN Biosciences
🚀Flexperc Medical
🚀GelSana Therapeutics, Inc.
🚀Immunova Therapeutics
🚀Jaan Biotherapeutics L.L.C.
🚀JAL Therapeutics
🚀Level 42 AI, Inc.
🚀Minutia
🚀ParaMag Biosciences
🚀Scopi Medical
🚀Siege Pharmaceuticals
🚀Synthis Therapeutics

Each will be matched with a custom advisory team based on their unique business and commercialization goals. In its 10th year, FAST has helped 100+ innovative startups perfect their business plans and commercialization strategies! LEARN MORE: https://bit.ly/3ZgzFj4

04/16/2022

Level 42 AI is delighted to be part of Operation Warp Speed, collaborating with the Geneva Foundation and 4D3Bio https://lnkd.in/eYgeT8KT, to showcase how and health information hidden in can be leveraged to help the world turn the corner on the and prepare for the next pandemic in an and way.

Researchers with The Geneva Foundation under the USU-4DBio3 Center for Biotechnology (4D Bio3) are working to develop adaptable tools to detect the presence of SARS-CoV-2 and other dangerous pathogens in less than three minutes using breathalyzer technology and detection through audible sound.

04/15/2022

This is exciting! What if there was a handheld device, with the same accuracy and lower cost available?

With high sensitivity and specificity, results returned in under 3 minutes

04/10/2022

In the news:

In-person demo days are back, and these startups are vying for investors' attention.

04/07/2022

Yesterday our CEO Shasha Jumbe presented Level 42 AI at Berkeley Skydeck , along with 18 other fantastic startups. We have all worked long and hard over 6 months to sharpen our skills as we at the same time continue to build our products and businesses. Demo Day is the culmination of all this hard work where we get in front of 1000+ invited investors, in person and virtual. Given all the interest we saw all around we will be even busier going forward. Big thank you to all SkyDeck staff and advisors putting this together!

09/02/2021

African Diaspora Network is delighted to announce the inaugural cohort of Accelerating Black Leadership and Entrepreneurship (ABLE).

The 16 ABLE entrepreneurs stand out for their unique and sustainable solution to a community need; demonstrate traction with their enterprise throughout the pandemic, and clear goals to scale their ventures. Read the press release and meet the cohort at https://africandiasporanetwork.org/able/

Bill.com Silicon Valley Community Foundation County of Santa Clara, California California Black Freedom Fund Santa Clara University

09/02/2021

SVCF & the California Black Freedom Fund are proud to fund Accelerating Black Leadership & Entrepreneurship (ABLE), an enterprise accelerator program by African Diaspora Network designed to strengthen, energize & support small businesses & led by Black entrepreneurs in the US.

African Diaspora Network is delighted to announce the inaugural ABLE cohort. The 16 entrepreneurs stand out for their unique & sustainable solution to a community need & clear goals to scale their ventures. Meet the cohort. >>> http://africandiasporanetwork.org/able/

03/26/2021

Enjoyed the Axios virtual-event today “A conversation on COVID-19 testing post vaccines”. Some of the world’s foremost experts discussed the current state of testing for COVID-19 and what we need to do to ensure our society safely gets back to work, school, and life.

https://www.axios.com/rapid-covid-testing-bf40070e-8b09-4778-a17e-72a72023f2a9.html

Jennifer Nuzzo from Johns Hopkins discussed the need for sufficient disease surveillance across regions and populations
Michael Mina from Harvard suggested the need for entrance screening for schools and offices – this will reduce spread of infection by 90%
Deepak Nath from Siemens highlighted that COVID-19 will be with us for a while, he stated 25% of the US population are kids and they are not eligible for vaccination till the end of 2021.
Michael Osterholm University of Minnesota said we need to continue to make testing readily available so we can ensure schools and travel is safe

All experts agree that:

COVID-19 variants are a problem and will persist
1 - We Need More Testing!
2 - Testing should be here to stay; must be easy and affordable
3 - Vaccine passports ARE not an equitable solution
4 - Must increase testing for vaccine durability

Level42 AI helps solve the testing issue as it’s Impulse dCoder™ provides a cost-effective, fast, accurate, non-contact COVID-19 screening solution that can be placed at points of entry at schools, office buildings, airports and beyond.

"We need rapid tests that are ubiquitous, that we can use in lots of different places"